ADARx Pharmaceuticals Raises $446.3 Million in Upsized US IPO
ADARx Pharmaceuticals raised $446.3 million in an upsized US initial public offering, pricing 26.3 million shares at $17 each, the top end of its marketed range. The San Diego-based biotech had initially planned to...
Electra Therapeutics Targets Up to $978 Million Valuation in U.S. IPO
Drug developer Electra Therapeutics is targeting a valuation of up to $977.6 million in its U.S. initial public offering, according to a filing on Monday, adding to a broader recovery in biotech listings this...
GSK to Invest £400 Million in UK R&D Expansion
British pharmaceutical company GSK announced a £400 million investment over the next three years to strengthen its UK operations, including relocating its research and development activities to a new Cambridge facility. The move is...